Extracorporeal membrane oxygenation increases bleeding risk in patients with cardiogenic shock
1. 30-day mortality was comparable among patients on VA-ECMO and medical therapy alone. 2. VA-ECMO was associated with increased adverse ...
1. 30-day mortality was comparable among patients on VA-ECMO and medical therapy alone. 2. VA-ECMO was associated with increased adverse ...
1. The 30-day mortality was not significantly lower in the group treated with moderate hypothermia during venoarterial extracorporeal membrane oxygenation ...
1. Mortality rate increased from 36.9% to 51.9% from early 2020 (before May 1) to late 2020 (after May 2) ...
1. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) use in cardiogenic shock has been linked to a potentially harmful increase in left ...
1. Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) did not show a 60-day mortality benefit compared ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.